RMD Form 144: Director Seeks to Sell 4,991 Shares

RMD filed a Form 144 reporting a proposed sale of 4,991 common shares by Michael Farrell.

Rhea-AI Filing Summary

RMD filed a Form 144 reporting a proposed sale of 4,991 common shares by Michael Farrell.

The filing states the sale is pursuant to options granted 11/21/2019 and lists the trade date as 03/09/2026 with a cash transaction method. The filing also records two prior sales by the same person: 01/07/2026 (4,991 shares, $1,240,065.36) and 02/09/2026 (4,991 shares, $1,366,436.48).

Insights

Corporate Governance Specialist

Routine insider resale under Rule 144; transactions documented.

The filing lists a proposed sale of 4,991 common shares by Michael Farrell dated 03/09/2026, tied to options granted 11/21/2019. It documents prior sales on 01/07/2026 and 02/09/2026 with stated aggregate proceeds.

Disclosure aligns with Rule 144 mechanics: the notice records planned resale and recent activity. Cash‑flow treatment is shown as cash and the filing names the brokerage. Subsequent filings will show whether the sale executed.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the RMD Form 144 filed by Michael Farrell report?

The filing reports a proposed sale of 4,991 common shares by Michael Farrell on 03/09/2026. It notes the shares relate to options granted 11/21/2019 and that the sale method is listed as cash.

Has Michael Farrell sold RMD shares recently before this Form 144?

Yes. The filing records two prior sales: 01/07/2026 of 4,991 shares for $1,240,065.36, and 02/09/2026 of 4,991 shares for $1,366,436.48. These are shown in the ‘past 3 months’ section.

Are the proceeds and sale method specified in the RMD Form 144?

The filing indicates the sale method as cash and shows dollar amounts for recent past sales: $1,240,065.36 and $1,366,436.48. The proposed sale lists only the share count and trade date.

Do the shares in the Form 144 come from option exercises?

The filing ties the shares to options granted 11/21/2019, indicating the shares relate to option‑based awards. The document links the proposed sale date 03/09/2026 to those options.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/09/2026 - 11:24 AM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001485164
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	RESMED INC
SEC File Number	001-15317
Address of Issuer	9001 SPECTRUM CENTER BLVD. SAN DIEGO CALIFORNIA 92123
Phone	8587462400
Name of Person for Whose Account the Securities are To Be Sold	Farrell Michael J.
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	4991	1248149.28	145678401	03/09/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/09/2026	Options Granted 11/21/2019	Issuer			4991	03/09/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Michael Farrell 9001 Spectrum Center Blvd. San Diego CA 92123	Common	01/07/2026	4991	1240065.36
Michael Farrell 9001 Spectrum Center Blvd. San Diego CA 92123	Common	02/09/2026	4991	1366436.48

144: Remarks and Signature

Remarks
Date of Notice	03/09/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	10/31/2024
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Audrey McMillen, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Michael Farrell
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)